Valbiotis SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1.51 million compared to EUR 0.748 million a year ago. Net loss was EUR 5.1 million compared to EUR 3.47 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.995 EUR | +1.40% | +1.78% | -20.10% |
04-26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.10% | 66.59M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.65% | 22.18B | |
-16.67% | 21.2B | |
-9.10% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ALVAL Stock
- News VALBIOTIS
- Valbiotis SA Reports Earnings Results for the Half Year Ended June 30, 2022